Adiponectin (ADP) is one of the key adipokines with various beneficial effects related to obesity and metabolic syndromes, including improving glucose and lipid metabolism, enhancing insulin sensitivity, reducing oxidative stress and inflammation, promoting ceramides degradation, and stimulating adipose tissue vascularity [41]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.